William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
Verve Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Verve Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Verve Therapeutics (VERV) Prices Upsized 8.33M Share Offering at $27/sh
-
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
Verve Therapeutics (VERV) Announces Proposed $200M Share Offering
-
Verve Therapeutics Announces Proposed Public Offering of Common Stock
-
Verve Therapeutics Announces Proposed Public Offering of Common Stock
-
Verve Therapeutics (VERV) 101 Presentations and Data Reaffirm the Company's Best in Class Status - William Blair
-
UPDATE: William Blair Starts Verve Therapeutics (VERV) at Outperform
-
Verve Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Verve Therapeutics (VERV) IPO Opens 58% Higher
-
Verve Therapeutics (VERV) IPO Prices at $19
-
Verve Therapeutics Announces Pricing of Initial Public Offering

